Image for illustrative purposes only. Not a real photo.

Amplia initiates Phase 2b pancreatic cancer trial

Written by Jon CuthbertPublished May 19, 2026, 12:16 AMLast Updated Jul 6, 2026, 10:11 AM

Amplia Therapeutics (ASX:ATX) initiated the first stage of a registration-enabling Phase 2b clinical trial for its drug candidate, narmafotinib.

More ways to discover